Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Clinical Chemistry and Laboratory Medicine|August 11, 2021
Distribution of HOMA-IR in a population-based cohort and proposal for reference intervalsBassel Matli, Andreas Schulz, Thomas Koeck, et al.
Clinical Chemistry and Laboratory Medicine|May 11, 2023
One fits all: a highly sensitive combined ddPCR/pyrosequencing system for the quantification of microchimerism after hematopoietic and solid organ transplantationFriederike Häuser, Jens Mittler, Misra Simge Hantal, et al.
Hamostaseologie|July 30, 2021
COVID-19 as a Potential Trigger for Immune Thrombotic Thrombocytopenic Purpura and Reason for an Unusual Treatment: A Case ReportMarie-Kristin Schwaegermann, Lukas Hobohm, Johanna Rausch, et al.
Blood Advances|July 3, 2023
A novel von Willebrand factor multimer ratio as marker of disease activity in thrombotic thrombocytopenic purpuraTanja Falter, Heidi Rossmann, Laure de Waele, et al.
Journal of Clinical Medicine|February 12, 2021
No Evidence for Classic Thrombotic Microangiopathy in COVID-19Tanja Falter, Heidi Rossmann, Philipp Menge, et al.
Blood Advances|September 8, 2021
Anti-ADAMTS13 autoantibody profiling in patients with immune-mediated thrombotic thrombocytopenic purpuraKadri Kangro, Elien Roose, Bérangère S Joly, et al.
Journal of Thrombosis and Haemostasis : JTH|October 22, 2023
Open ADAMTS-13 conformation index predicts earlier relapse in immune-mediated thrombotic thrombocytopenic purpuraLaure De Waele, Kazuya Sakai, Ilaria Mancini, et al.
Journal of Thrombosis and Haemostasis : JTH|July 9, 2021
Pathogenic lipid-binding antiphospholipid antibodies are associated with severity of COVID-19Anne Hollerbach, Nadine Müller-Calleja, Denise Pedrosa, et al.
Journal of Thrombosis and Haemostasis : JTH|November 10, 2020
Immunogenic hotspots in the spacer domain of ADAMTS13 in immune-mediated thrombotic thrombocytopenic purpuraLeydi Carolina Velásquez Pereira, Elien Roose, Nuno A G Graça, et al.
Pageof 3